Physician profile
Mabel Yew
NPI 1922382126
$320.84
in general payments reported to CMS, 2019-2025
10 companies · $24.39 in 2025
The $24.39 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102 · 2020: $41.28 · 2021: $13.20 · 2022: $34.07 · 2023: $79.16 · 2024: $26.98 · 2025: $24.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $130.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $93.62 | 2019-2025 | Shingrix, Arexvy |
| Pfizer INC. | $41.39 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $38.03 | 2019-2020 | |
| Amarin Pharma, INC. | $29.70 | 2020 | |
| Medtronic, INC. | $28.67 | 2023 | Venaseal |
| Biohaven Pharmaceutical Holding Company LTD. | $22.42 | 2022 | |
| Sanofi Pasteur INC. | $22.30 | 2023 | |
| Amgen INC. | $20.89 | 2019 | |
| Sanofi-Aventis U.S. LLC | $12.17 | 2019 | |
| Merck Sharp & Dohme LLC | $11.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mabel Yew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.